Related Experiment Videos
Pancreastatin and islet hormone release
S Efendić1, K Tatemoto, V Mutt
1Department of Endocrinology, Karolinska Hospital, Stockholm, Sweden.
Summary
Pancreastatin significantly suppresses insulin release from pancreatic islets, potentially contributing to non-insulin-dependent diabetes. Further research into pancreastatin
Area of Science:
- Endocrinology
- Metabolic Research
- Pancreatic Physiology
Background:
- Pancreastatin is a peptide hormone involved in glucose homeostasis.
- Dysregulation of islet hormone secretion is a hallmark of diabetes.
Purpose of the Study:
- To investigate the effects of pancreastatin on insulin, glucagon, and somatostatin release.
- To explore the role of pancreastatin in pancreatic islet function and potential relevance to diabetes.
Main Methods:
- Isolated perfused rat pancreas and isolated rat islets were used.
- Pancreastatin was administered during perfusion with glucose or arginine.
- Hormone release (insulin, glucagon, somatostatin) was measured.
Main Results:
- Pancreastatin suppressed glucose- and arginine-stimulated insulin release.
- Pancreastatin partially reduced arginine-induced somatostatin release.
- Pancreastatin showed a trend towards augmenting arginine-induced glucagon release.
Conclusions:
- Pancreastatin modulates islet hormone secretion in a manner similar to that observed in non-insulin-dependent diabetes.
- Pancreastatin's role in islet physiology and pathophysiology warrants further investigation.